WO2004089386A8 - 消化酵素に対する鶏卵抗体を用いた抗肥満剤 - Google Patents
消化酵素に対する鶏卵抗体を用いた抗肥満剤Info
- Publication number
- WO2004089386A8 WO2004089386A8 PCT/JP2004/005006 JP2004005006W WO2004089386A8 WO 2004089386 A8 WO2004089386 A8 WO 2004089386A8 JP 2004005006 W JP2004005006 W JP 2004005006W WO 2004089386 A8 WO2004089386 A8 WO 2004089386A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- digestive enzymes
- hen
- antibody against
- egg antibody
- antiobestic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
- A23L15/25—Addition or treatment with microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002521997A CA2521997A1 (en) | 2003-04-10 | 2004-04-07 | Antiobestic agent using hen's egg antibody against digestive enzymes |
US10/552,062 US20060182730A1 (en) | 2003-04-10 | 2004-07-07 | Antiobesity agent using hen's egg antibody against digestive enzymes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003106670 | 2003-04-10 | ||
JP2003-106670 | 2003-04-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004089386A1 WO2004089386A1 (ja) | 2004-10-21 |
WO2004089386A8 true WO2004089386A8 (ja) | 2005-01-20 |
Family
ID=33156920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/005006 WO2004089386A1 (ja) | 2003-04-10 | 2004-04-07 | 消化酵素に対する鶏卵抗体を用いた抗肥満剤 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20060182730A1 (ja) |
KR (1) | KR20050121250A (ja) |
CA (1) | CA2521997A1 (ja) |
TW (1) | TW200507861A (ja) |
WO (1) | WO2004089386A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008013455A1 (en) * | 2006-07-27 | 2008-01-31 | Lactive B.V. | Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk |
US8501220B2 (en) | 2009-12-31 | 2013-08-06 | R&D Lifesciences | Stabilized liquid egg material for extended shelf life |
CN101792750A (zh) * | 2010-03-03 | 2010-08-04 | 珠海市英平生物科技有限公司 | 抗α-葡萄糖苷酶活性卵黄抗体及其抗原、制备方法和应用 |
JP6778488B2 (ja) * | 2013-12-02 | 2020-11-04 | オーストリッチファーマ株式会社 | 消化酵素抗体およびそれを有する卵と卵を原料とする加工品および抗体を含む組成物と製造方法 |
US10538593B2 (en) | 2013-12-02 | 2020-01-21 | Ostrich Pharma Kk | Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody |
KR101633791B1 (ko) * | 2014-05-15 | 2016-06-27 | 한남대학교 산학협력단 | 수크라아제-이소말타아제에 대한 항체의 제조 방법 |
CN115919834A (zh) * | 2022-07-27 | 2023-04-07 | 广西中医药大学 | Sclerotiorin作为α-葡萄糖苷酶抑制剂的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58225026A (ja) * | 1982-06-23 | 1983-12-27 | Mochida Pharmaceut Co Ltd | アミラ−ゼ活性および/またはリパ−ゼ活性亢進に起因する疾患の予防および治療剤 |
JPH02121908A (ja) * | 1988-10-28 | 1990-05-09 | Kanebo Ltd | にきび用化粧料 |
JPH0812584A (ja) * | 1994-06-27 | 1996-01-16 | Yakult Honsha Co Ltd | α−アミラーゼ活性阻害物質、その製造法及びこれを含有する糖尿病の予防・治療剤 |
US7344713B1 (en) * | 1997-07-07 | 2008-03-18 | Pimentel Julio L | Decreased fat absorption with an anti-lipase antibody |
JP4795512B2 (ja) * | 2000-07-14 | 2011-10-19 | 日本サプリメント株式会社 | α−グルコシダーゼ阻害剤の製造法 |
KR100435829B1 (ko) * | 2001-09-24 | 2004-06-12 | (주)바이오랩 | 수크라아제와 말타아제에 대한 난황항체의 생산방법 및이를 이용한 식이 탄수화물의 흡수 억제용 조성물 |
JP2003192695A (ja) * | 2001-12-27 | 2003-07-09 | National Institute Of Advanced Industrial & Technology | アンジオテンシンi変換酵素阻害剤 |
JP2003259884A (ja) * | 2002-01-07 | 2003-09-16 | Kyowa Hakko Kogyo Co Ltd | 新規ポリペプチド |
KR20030068728A (ko) * | 2002-02-16 | 2003-08-25 | (주)바이오랩 | 췌장 아밀라아제에 대한 난황항체의 생산방법 및 이를이용한 식이 탄수화물의 흡수 억제용 조성물 |
-
2004
- 2004-04-07 CA CA002521997A patent/CA2521997A1/en not_active Abandoned
- 2004-04-07 KR KR1020057019093A patent/KR20050121250A/ko not_active Application Discontinuation
- 2004-04-07 WO PCT/JP2004/005006 patent/WO2004089386A1/ja active Application Filing
- 2004-04-07 TW TW093109635A patent/TW200507861A/zh unknown
- 2004-07-07 US US10/552,062 patent/US20060182730A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20050121250A (ko) | 2005-12-26 |
CA2521997A1 (en) | 2004-10-21 |
US20060182730A1 (en) | 2006-08-17 |
TW200507861A (en) | 2005-03-01 |
WO2004089386A1 (ja) | 2004-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE238415T1 (de) | Feste phytase-zusammensetzungen | |
IL176478A0 (en) | Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme | |
WO2003093441A3 (en) | A method of regulating gene expression | |
WO2005123116A3 (en) | Compositions and methods for treating or preventing oxalate-related disease | |
AU2002360488A1 (en) | Methods and devices for detection and therapy of atheromatous plaque | |
EP2308979A3 (en) | Alpha-amylase mutants with altered properties | |
WO2007058942A3 (en) | Imidazopyrazines as protein kinase inhibitors | |
HK1044545A1 (zh) | 貝他分泌酶組合物及其方法 | |
WO2008057458A3 (en) | Antagonists of pcsk9 | |
AU2003220299A1 (en) | Azinylaminoazoles as inhibitors of protein kinases | |
AU2003218215A1 (en) | Azolylaminoazines as inhibitors of protein kinases | |
AU2003220300A1 (en) | Compositions useful as inhibitors of protein kinases | |
WO2005105829A3 (en) | Caspase-2 inhibitors and their biological applications | |
AU2003300368A1 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
AU2002953327A0 (en) | Methods of diagnosing prognosing and treating activin associated diseases and conditions | |
WO2007120651A3 (en) | Uses and compositions for treatment of juvenile rheumatoid arthritis | |
WO2001017543A3 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
WO2005123913A3 (en) | Reversibly modified thermostable enzyme compositions and methods of making and using the same | |
WO2004052236A3 (en) | Methods and compositions for treatment of otitis media | |
WO2004089386A8 (ja) | 消化酵素に対する鶏卵抗体を用いた抗肥満剤 | |
AU2001258373A1 (en) | Method for identifying helicobacter antigens | |
WO2004043348A3 (en) | Histone deacetylase inhibitors for treating degenerative diseases of the eye | |
WO2004027418A3 (en) | The use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity | |
AU2003235506A1 (en) | Targeted enzymes and methods of making and using targeted enzymes. | |
WO2000064422A3 (en) | Novel treatment of neurotraumatic conditions with raf inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 43/2004 UNDER (22) REPLACE "7 MARCH 2004 (07.03.2004)" BY "7 APRIL 2004 (07.04.2004)" |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005505304 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006182730 Country of ref document: US Ref document number: 10552062 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057019093 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2521997 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057019093 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 10552062 Country of ref document: US |